Auryxia Alternatives Compared
| Auryxia | Renvela | Sevelamer |
|
|---|
| Auryxia (ferric citrate) | Renvela (sevelamer) | Sevelamer |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperphosphatemia of Renal Failure, Iron Deficiency Anemia. Auryxia may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperphosphatemia of Renal Failure. Renvela may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperphosphatemia of Renal Failure. Sevelamer may also be used for purposes not listed in this medication guide. |
Related suggestions Hyperphosphatemia of Renal Failure
|
|||||||||||||||||||||||
| More about Auryxia (ferric citrate) | More about Renvela (sevelamer) | More about Sevelamer | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Auryxia has an average rating of 6.3 out of 10 from a total of 7 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 43% reported a negative effect. |
Renvela has an average rating of 5.0 out of 10 from a total of 7 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 50% reported a negative effect. |
Sevelamer has an average rating of 5.1 out of 10 from a total of 16 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Auryxia prices |
View all Renvela prices |
View all Sevelamer prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other sevelamer brands include: Renagel | Renagel, Renvela | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
1 hour |
1 hour |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 52 drugs are known to interact with Auryxia:
|
A total of 43 drugs are known to interact with Renvela:
|
A total of 43 drugs are known to interact with Sevelamer:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 05, 2014 |
October 19, 2007 |
July 12, 2000 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.